The gut-liver-kidney-brain axis in Wilson disease: copper speciation-flux and barrier-mediated organ crosstalk - Takeaways - MDSpire

The gut-liver-kidney-brain axis in Wilson disease: copper speciation-flux and barrier-mediated organ crosstalk

  • By

  • Nannan Qian

  • Sihuan Zhu

  • Yuqi Song

  • Yulong Yang

  • Han Wang

  • Hui Han

  • Guocun Xu

  • Wenjie Hao

  • Hailin Jiang

  • Yue Yang

  • Hu Xi

  • Yufeng Ding

  • Wei He

  • Taohua Wei

  • Wenming Yang

  • Ting Cheng

  • June 17, 2026

  • 0 min

Share

  • 1

    Wilson disease (WD) is evolving from a liver-centric view to a model emphasizing the gut-liver-kidney-brain axis.

  • 2

    Copper circulates in bioactive pools, disrupting barriers and causing toxicity through biochemical mediators.

  • 3

    Gut dysbiosis exacerbates hepatic inflammation and copper retention, as shown in studies with ATP7B-deficient mice.

  • 4

    Clinical approaches are shifting towards biomarkers and interventions targeting biliary copper excretion and barrier repair.

  • 5

    The gut-liver-kidney-brain axis model explains WD's phenotypic heterogeneity and supports more precise therapeutic strategies.

Original Source(s)

The gut-liver-kidney-brain axis in Wilson disease: copper speciation-flux and barrier-mediated organ crosstalk

  • by Nannan Qian, Sihuan Zhu, Yuqi Song, Yulong Yang, Han Wang, Hui Han, Guocun Xu, Wenjie Hao, Hailin Jiang, Yue Yang, Hu Xi, Yufeng Ding, Wei He, Taohua Wei, Wenming Yang, Ting Cheng

  • June 17, 2026

Related Content

Nurr1 deficiency orchestrates a coupled liver–gut pathological axis revealed by multi-omics and deep-learning histopathology

Microbiota metabolite butyrate alleviates intestinal inflammation associated with enhanced autophagy-related signaling in DSS-induced colitis

Macrophage dysregulation in inflammatory bowel disease: cellular heterogeneity, pathogenic mechanism, and treatment